[HTML][HTML] Current role of total laryngectomy in the era of organ preservation
A Bozec, D Culié, G Poissonnet, O Dassonville - Cancers, 2020 - mdpi.com
In this article, we aimed to discuss the role of total laryngectomy (TL) in the management of
patients with larynx cancer (LC) in the era of organ preservation. Before the 1990s, TL …
patients with larynx cancer (LC) in the era of organ preservation. Before the 1990s, TL …
Moderately Hypofractionated Intensity-modulated Radiotherapy With a Simultaneous Integrated Boost for Locally Advanced Head and Neck Cancer–Do Modern …
J Wichmann, M Durisin, RM Hermann, R Merten… - in vivo, 2021 - iv.iiarjournals.org
Background: Intensity-modulated radiotherapy (IMRT) with simultaneous integrated boost
(SIB) and moderate hypofractionation offers an opportunity for defining individual doses and …
(SIB) and moderate hypofractionation offers an opportunity for defining individual doses and …
[HTML][HTML] Initial experience of intentional internal high-dose policy volumetric modulated arc therapy of neck lymph node metastases≥ 2 cm in patients with head and …
T Kashihara, S Nakamura, N Murakami, K Ito… - Frontiers in …, 2021 - frontiersin.org
Background and Purpose Most locoregional recurrences after definitive radiotherapy for
head and neck squamous cell carcinoma (HNSCC) develop “in-field.” Dose escalation while …
head and neck squamous cell carcinoma (HNSCC) develop “in-field.” Dose escalation while …
A Retrospective Study of Chemotherapy and 3D‐Image‐Guided Afterloading Intracavitary Radiotherapy in Locally Advanced Cervical Cancer
X Li, C An, C Feng, J Sun, H Lu, X Yang… - Journal of …, 2022 - Wiley Online Library
Aim. To investigate the value of neoadjuvant chemotherapy combined with 3D‐image‐
guided afterloading intracavitary radiotherapy in locally advanced cervical cancer (LACC) …
guided afterloading intracavitary radiotherapy in locally advanced cervical cancer (LACC) …
[PDF][PDF] Tumour volume and radiotherapy prolongation in locally advanced head and neck cancer patients treated with radical IMRT
R Lohynska, M Jirkovska, B Malinova… - Biomedical …, 2022 - academia.edu
Aims. The relationship of tumour volume, radiotherapy treatment time and other prognostic
factors affecting prognosis was evaluated. Methods. 184 patients with locally advanced …
factors affecting prognosis was evaluated. Methods. 184 patients with locally advanced …
[HTML][HTML] Risk factors for radiation-induced lung injury in patients with advanced non-small cell lung cancer: implication for treatment strategies
S Sha, J Dong, M Wang, Z Chen, P Gao - World Journal of Surgical …, 2021 - Springer
Background The radiation-induced lung injury (RILI) in patients with advanced non-small
cell lung cancer (NSCLS) is very common in clinical settings; we aimed to evaluate the risk …
cell lung cancer (NSCLS) is very common in clinical settings; we aimed to evaluate the risk …
[PDF][PDF] 三维适形放疗联合GT 化疗方案对晚期膀胱癌患者免疫功能, 生活质量及肿瘤标志物水平的影响
郑超， 陈超， 赵磊， 高浚臣… - Progress in Modern …, 2022 - biomed.cnjournals.com
摘要目的: 探讨三维适形放疗联合吉西他滨及多西他赛(GT) 化疗方案对晚期膀胱癌患者免疫
功能, 生活质量及肿瘤标志物水平的影响. 方法: 选取2015 年3 月~ 2018 年8 …
功能, 生活质量及肿瘤标志物水平的影响. 方法: 选取2015 年3 月~ 2018 年8 …
[PDF][PDF] 调强适形放疗联合替莫唑胺对脑胶质瘤患者生命质量及血清VEGF, EGF 水平的影响
曹杰， 张杰， 李民， 孟发财， 蔺鹏帧… - Progress in Modern …, 2021 - biomed.cnjournals.com
摘要目的: 探讨调强适形放疗联合替莫唑胺对脑胶质瘤患者生命质量及血清表皮生长因子(EGF),
血管内皮生长因子(VEGF) 水平的影响. 方法: 选取我院于2015 年3 月到2017 年2 …
血管内皮生长因子(VEGF) 水平的影响. 方法: 选取我院于2015 年3 月到2017 年2 …
同步整合加量调强联合选择性淋巴结照射根治性治疗食管鳞癌的长期预后分析.
李运华， 颜学军， 谭亚丽， 胡亚… - Tianjin Medical …, 2021 - search.ebscohost.com
目的探讨同步整合加量调强(SIB-IMRT) 联合选择性淋巴结照射(ENI) 加或不加化疗根治性治疗
食管鳞癌患者的长期预后. 方法对130 例接受根治性放(化) 疗的食管鳞癌患者进行回顾性分析 …
食管鳞癌患者的长期预后. 方法对130 例接受根治性放(化) 疗的食管鳞癌患者进行回顾性分析 …
[HTML][HTML] Nebenwirkungen und Tumorkontrolle nach Radiochemotherapie bei Patienten mit Ösophaguskarzinom
V Lussac - 2021 - refubium.fu-berlin.de
Multimodale Therapiemöglichkeiten haben sich als Standard in der Behandlung von
Patienten mit einem Ösophaguskarzinom etabliert. Die Radiochemotherapie wird vor …
Patienten mit einem Ösophaguskarzinom etabliert. Die Radiochemotherapie wird vor …